CLEVELAND — Researchers narrowed down what appears to be the correct dosage during a first ever rigorous clinical trial examining LSD as a treatment for generalized anxiety disorder, with results ...
The US Food and Drug Administration (FDA) has granted breakthrough designation to an LSD-based treatment for generalized anxiety disorder (GAD) based on promising topline data from a phase 2b clinical ...
In the mental health field, we tend to pathologize and diagnose even commonly encountered challenges. Through the lens of human experience, however, we can recognize that some emotional and mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback